Additionally, aging and metabolic diseases are known to potentiate fibroblast activation [11]; therefore, incorporating aged cohorts and models of comorbid conditions (e.g., diabetes, hypertension) will be important to further define how these systemic factors shape PostnLin cell activation and fibrogenic response to AngII. The gene discussed is AGT; the disease is metabolic disease.